Search

everythinglearnresearchcommunity

for

Search:↓

Triamcinolone regrows hair better but relapses more than anthralin.

Higher Alarin levels may predict androgenetic alopecia and metabolic syndrome.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Finasteride helps female-pattern hair loss.

Trichoscopy is a useful non-invasive method to diagnose female hair loss with high accuracy.

Lasers and energy-based devices effectively and safely improve hair growth in androgenetic alopecia, especially when combined with other treatments.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Korean adolescents with androgenetic alopecia often have a family history, milder symptoms than adults, and normal hormone levels.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Combining anti-androgenic, anti-inflammatory, and anti-fibrotic treatments may improve hair loss outcomes.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

Scalp dermoscopy is good for diagnosing a type of hair loss and helps choose the best spots for biopsy.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Combining anti-androgenic, anti-inflammatory, and anti-fibrotic treatments may improve hair loss outcomes, but more testing is needed.

Fire needle therapy's benefits and safety for alopecia areata need more evidence.

The study concluded that short vellus hair and yellow dots were the most common signs of alopecia areata, indicating disease activity and remission.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Perifollicular fibrosis hinders hair regrowth in androgenetic alopecia, and new treatments targeting fibrosis are needed.

Finasteride 1 mg/day effectively treats hair loss in men aged 18-41 and over 41; DEET lotion works better than herbal insect repellents; combined tattoo removal technique shows no extra benefits.

Transverse sectioning is more reliable for diagnosing alopecia areata.

Androgenetic alopecia may be irreversible due to the detachment of a muscle from hair follicles.

Yellow dots look different in various hair loss conditions and can help diagnose them.